Chemoinformaics analysis of 8-Methyl-7-propanoylindolizino[1,2-b]quinolin-9(11h)-one
| Molecular Weight | 304.349 | nRot | 2 |
| Heavy Atom Molecular Weight | 288.221 | nRig | 22 |
| Exact Molecular Weight | 304.121 | nRing | 4 |
| Solubility: LogS | -6.798 | nHRing | 3 |
| Solubility: LogP | 3.76 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 46.2027 |
| nHD | 0 | BPOL | 20.6373 |
| QED | 0.534 |
| Synth | 2.485 |
| Natural Product Likeliness | -0.127 |
| NR-PPAR-gamma | 0.292 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.694 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.776 |
| MDCK | 0.0000255 |
| BBB | 0.399 |
| PPB | 0.95336 |
| VDSS | 0.613 |
| FU | 0.015264 |
| CYP1A2-inh | 0.894 |
| CYP1A2-sub | 0.654 |
| CYP2c19-inh | 0.779 |
| CYP2c19-sub | 0.136 |
| CYP2c9-inh | 0.822 |
| CYP2c9-sub | 0.352 |
| CYP2d6-inh | 0.111 |
| CYP2d6-sub | 0.586 |
| CYP3a4-inh | 0.589 |
| CYP3a4-sub | 0.206 |
| CL | 5.961 |
| T12 | 0.19 |
| hERG | 0.134 |
| Ames | 0.514 |
| ROA | 0.053 |
| SkinSen | 0.044 |
| Carcinogencity | 0.437 |
| EI | 0.231 |
| Respiratory | 0.221 |
| NR-Aromatase | 0.805 |
| Antiviral | Yes |
| Prediction | 0.73469 |